Die Bedeutung des sensorischen Nervensystems für die Repigmentierung der Haut bei Vitiligo (engl.: The role of the sensory nervous system for repigmentation in vitiligo)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2006-000838-12-AT

Enrollment

Registered

2006-06-29

Start date

2006-08-03

Completion date

Unknown

Last updated

2016-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo

Interventions

Product Name: Capsaicin 0.05% Creme Pharmaceutical Form: Cream Pharmaceutical form of the placebo: Cream Route of administration of the placebo: Cutaneous use

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Vitiligo Vitiligo for more than 6 months Age > 18 years Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Present or past Malignant Melanoma or Autoimmundiseases (Lupus erythemathosus, Dermatomyositis) Immundeficiency Systemic Treatment with corticosteroids and/or other immunosuppressive drugs Pregnancy or Lactation UV-treatment of the vitiliginous skin areas under investigation within last 2 weeks Significant Reduction in general health condition

Design outcomes

Primary

Measure	Time frame
Main Objective: To test whether repeated stimulation of the skin's sensory nervous system via cutaneous application of a capsaicin-containing cream affects the repigmentation of vitiliginous skin areas ;Secondary Objective: ;Primary end point(s): Area and Intensity of repigmentation of vitiliginous skin	—

Countries

Austria

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026